TY - JOUR AU - Lim, Renly AU - Thornton, Christopher AU - Stanek, Jan AU - Ellett, Lisa Kalisch AU - Thiessen, Myra PY - 2022 DA - 2022/10/7 TI -基于web的报告药物相关不良反应系统的开发:设计和可用性研究JO - JMIR Form Res SP - e37605 VL - 6 IS - 10kw -药物不良反应KW -药物不良事件KW -数字健康KW -电子健康KW -用药安全KW -移动健康KW -参与性设计KW -患者报告结果KW -远程医疗AB -背景:药物使用是卫生保健中最常见的干预措施。使用药物的频率意味着与药物相关的问题非常普遍。一种常见的药物相关问题是药物不良事件，这是与药物使用相关的意外和有害影响。向监管部门报告药品不良事件对药品安全性评价具有重要意义;然而，由于各种因素，包括缺乏对消费者友好的报告工具，这些不良影响往往未被报告。目的:本研究的目的是开发一个用户友好的数字工具，供消费者报告药物相关的不良反应。方法:项目分为三个部分:(1)内容开发，包括系统的文献检索;(2)迭代系统开发;(3)可用性测试。 The project was guided by participatory design principles, which suggest involving key stakeholders throughout the design process. The first 2 versions were developed as a mobile app and were tested with end users in 2 workshops. The third version was developed as a web application and was tested with consumers who were taking regular medicines. Consumers were asked to complete a modified version of the mHealth app usability questionnaire (MAUQ), an 18-item questionnaire with each item scored using a 7-point Likert scale ranging from 0 (strongly disagree) to 7 (strongly agree). The MAUQ assessed 3 subscales including ease of use (5 items), interface and satisfaction (7 items), and usefulness (6 items). Continuous variables were reported as mean (SD) values, whereas categorical variables were presented as frequencies (percentages). Data analysis was conducted in Microsoft Excel. Results: The content for the system was based on a systematic literature search and short-listing of questions, followed by feedback from project team members and consumers. Feedback from consumers in the 2 workshops were incorporated to improve the functionality, visual design, and stability of the third (current) version. The third version of the system was tested with 26 consumers. A total of 79% (N=307/390) of all responses on the MAUQ were scored 6 or 7, indicating that users generally strongly agree with the usability of the system. When looking at the individual domains, the system had an average score of 6.3 (SD 0.9) for “ease of use,” 6.3 (SD 0.8) for “interface and satisfaction,” and 5.2 (SD 1.4) for “usefulness.” Conclusions: The web-based system for medicine adverse effects reporting is a user-friendly tool developed using an iterative participatory design approach. Future research includes further improving the system, particularly the usefulness of the system, as well as testing the scalability and performance of the system in practice. SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/10/e37605 UR - https://doi.org/10.2196/37605 UR - http://www.ncbi.nlm.nih.gov/pubmed/36206034 DO - 10.2196/37605 ID - info:doi/10.2196/37605 ER -